Inventor · disambiguated record
Joel S. Parker
Also filed as: PARKER JOEL · PARKER JOEL S
6 granted patents·17 pending applications·14 citations·filing 2009–2024
77Inventor score
Files withUNIV NORTH CAROLINA CHAPEL HILL7GENECENTRIC THERAPEUTICS INC3LIFE EDIT THERAPEUTICS INC3PEROU CHARLES M2UNIV NORTH CAROLINA2
Top patents by PatentIndex Score
23 records- 0188US11851715B2Detecting cancer cell of originGENECENTRIC THERAPEUTICS INC·Filed 2022·Granted Dec 26, 2023·1 cites·7 claims
- 0286US12473539B2RNA-guided nucleases and active fragments and variants thereof and methods of useLIFE EDIT THERAPEUTICS INC·Filed 2024·Granted Nov 18, 2025·0 cites·29 claims
- 0386US12435325B2RNA-guided nucleases and active fragments and variants thereof and methods of useLIFE EDIT THERAPEUTICS INC·Filed 2024·Granted Oct 7, 2025·0 cites·30 claims
- 0486US12398385B2RNA-guided nucleases and active fragments and variants thereof and methods of useLIFE EDIT THERAPEUTICS INC·Filed 2024·Granted Aug 26, 2025·0 cites·29 claims
- 0585US9631239B2Method of classifying a breast cancer instrinsic subtypePEROU CHARLES M·Filed 2009·Granted Apr 25, 2017·8 cites·9 claims
- 0679US2023250484A1Gene expression profiles to predict breast cancer outcomesUNIV NORTH CAROLINA CHAPEL HILL·Filed 2023·Application pending·0 cites
- 0776US2022213563A1Gene expression profiles to predict breast cancer outcomesUNIV NORTH CAROLINA CHAPEL HILL·Filed 2022·Application pending·0 cites
- 0874US9181588B2Methods of treating breast cancer with taxane therapyPEROU CHARLES M·Filed 2012·Granted Nov 10, 2015·5 cites·20 claims
- 0974US2023272476A1Nano46 genes and methods to predict breast cancer outcomeVERACYTE INC·Filed 2022·Application pending·0 cites
- 1071US2019264290A1Gene expression profiles to predict breast cancer outcomesUNIV NORTH CAROLINA CHAPEL HILL·Filed 2019·Application pending·0 cites
- 1170US2020040407A1Gene expression profiles to predict breast cancer outcomesUNIV NORTH CAROLINA CHAPEL HILL·Filed 2019·Application pending·0 cites
- 1264US2024425929A1Methylation markers for melanoma and uses thereofUNIV NORTH CAROLINA CHAPEL HILL·Filed 2024·Application pending·0 cites
- 1363US2020332368A1Nano46 genes and methods to predict breast cancer outcomeVERACYTE INC·Filed 2020·Application pending·0 cites
- 1463US2013337444A1NANO46 Genes and Methods to Predict Breast Cancer OutcomeNANOSTRING TECHNOLOGIES INC·Filed 2013·Application pending·0 cites
- 1561US2021388449A1Detecting cancer cell of originGENECENTRIC THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1660US2016153051A1Gene expression profiles to predict breast cancer outcomesUNIV NORTH CAROLINA·Filed 2015·Application pending·0 cites
- 1760US2016168645A1Gene expression profiles to predict breast cancer outcomesUNIV NORTH CAROLINA·Filed 2015·Application pending·0 cites
- 1849US2021398612A1Detecting tumor mutation burden with rna substrateGENECENTRIC THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1948US2024018597A1DNA Copy Number Alterations (CNAs) to Determine Cancer PhenotypesUNIV NORTH CAROLINA CHAPEL HILL·Filed 2020·Application pending·0 cites
- 2047US2023272474A1Methylation markers for melanoma and uses thereofUNIV NORTH CAROLINA CHAPEL HILL·Filed 2019·Application pending·0 cites
- 2135US2016017438A1Methods of treating breast cancer with taxane therapyUNIV UTAH RES FOUND·Filed 2015·Application pending·0 cites
- 2230US2012077687A1Prognostic and predictive gene signature for non-small cell lung cancer and adjuvant chemotherapySAAD FADIA·Filed 2011·Application pending·0 cites
- 2330US2016017431A1Methods for Predicting EGFR Tyrosine Kinase Inhibitor EfficacyDRIVER GROUP·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joel S. Parker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →